EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Immuno-oncological interactions between meningeal lymphatics and glioblastoma: from mechanisms to therapies

Nan Wen, Xiao Xiao, Huangjie Lu, Qingyuan Chen, Genghong He, Zhiyuan Qian, Jianfeng Zeng, Li Xiao

Theranostics · 09.06.2025 · 15 (14) · 6983-7000

DOI: 10.7150/thno.111972 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Theranostics, erschienen am 09.06.2025. Verfasst von Nan Wen und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital of Soochow University, Suzhou 215004, China. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Lymphatic Vessels, Meninges. Die Arbeit wurde bisher 13-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The recent discovery of meningeal lymphatic vessels (MLVs) has revolutionized our understanding of immune regulation within the central nervous system (CNS), overturning the long-standing view of the brain as an immune-privileged organ. Glioblastoma (GBM), the most aggressive primary brain tumor, remains therapeutically intractable due to its highly immunosuppressive microenvironment and poor response to conventional and immune-based therapies. Emerging evidence suggests that MLVs play a crucial role in CNS immune surveillance, cerebrospinal fluid drainage, and solute clearance, all of which are directly linked to GBM pathophysiology. This review is motivated by the urgent need to explore novel therapeutic strategies that address GBM's immune escape and therapeutic resistance. We comprehensively analyze the bidirectional interactions between MLVs and GBM, including their role in antigen transport, T cell activation, and tumor dissemination. Furthermore, we evaluate the therapeutic potential of targeting MLVs through lymphangiogenic stimulation or as alternative routes for immune modulation and drug delivery. These approaches offer promising avenues to enhance anti-tumor immunity and may pave the way for next-generation treatment paradigms in GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsLymphatic VesselsMeningesHumansAnimalsTumor Microenvironment

Stichwörter der Autor:innen

central nervous systemglioblastomaglymphatic systemimmune modulationmeningeal lymphatic vesselstumor therapy

Autor:innen und Institutionen

  • The Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
  • Center for Molecular Imaging and Nuclear Medicine, State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiologic…
  • Department of Radiology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.

Zitieren

APA

Wen, N., Xiao, X., Lu, H., Chen, Q., He, G., Qian, Z., Zeng, J., & Xiao, L. (2025). Immuno-oncological interactions between meningeal lymphatics and glioblastoma: from mechanisms to therapies. Theranostics, 15(14), 6983-7000. https://doi.org/10.7150/thno.111972

Vancouver

Wen N, Xiao X, Lu H, Chen Q, He G, Qian Z, et al. Immuno-oncological interactions between meningeal lymphatics and glioblastoma: from mechanisms to therapies. Theranostics. 2025;15(14):6983-7000. doi:10.7150/thno.111972

BibTeX
@article{Wen2025,
  author = {Wen, Nan and Xiao, Xiao and Lu, Huangjie and Chen, Qingyuan and He, Genghong and Qian, Zhiyuan and Zeng, Jianfeng and Xiao, Li},
  title = {Immuno-oncological interactions between meningeal lymphatics and glioblastoma: from mechanisms to therapies},
  journal = {Theranostics},
  year = {2025},
  volume = {15},
  number = {14},
  pages = {6983--7000},
  doi = {10.7150/thno.111972}
}
Kostenlos starten →